The National Institutes of Health’s National Center of Biotechnology Information (NCBI) recently announced plans to evaluate the clinical efficacy of hesperidin against COVID-19. Orange juice and sweet oranges contain hesperidin.
NCBI referred to hesperidin as “an old herbal medicine … used to treat vascular diseases in Europe and Australia and distributed with vitamin C as a dietary supplement in the USA.”
“Hesperidin is a promising drug candidate for the prevention and treatment of COVID-19,” NCBI continued. “Hesperidin interferes with viral entry through ACE2 receptors, improves the host cellular immunity, minimizes the release of inflammatory mediators and its mixture protects against venous thromboembolism.”
NCBI stated that “Hesperidin is a common flavone glycoside found in citrus fruit such as lemons and sweet oranges. Hesperidin has several pharmacological activities such as anti-atherogenic, antihyperlipidemic, antidiabetic, venotonic, cardioprotective, anti-inflammatory and …..
Learn more about Hesperidin to Be Tested Against COVID-19 on the Citrus Industry website.